Cargando…
One case of iodine-125 therapy – A new minimally invasive treatment of intrahepatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer associated with a poor prognosis. ICC accounts for about 10% of primary liver malignancies but with increasing incidence in recent years. Recently, some studies suggested that minimally interventional therapy can be...
Autores principales: | Chen, Xinju, Chen, Xiaoqi, Zhang, Chuanlei, Wang, Xinting, Yuan, Changwei, Yang, He, Yang, Lixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518658/ https://www.ncbi.nlm.nih.gov/pubmed/36249528 http://dx.doi.org/10.1515/biol-2022-0473 |
Ejemplares similares
-
Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: A systematic review
por: Patrone, Renato, et al.
Publicado: (2021) -
Minimally Invasive Surgery for Intrahepatic Cholangiocarcinoma: Patient Selection and Special Considerations
por: Owen, MacKenzie L, et al.
Publicado: (2021) -
Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma
por: Chen, Xing, et al.
Publicado: (2022) -
Apatinib as non-first-line treatment in patients with Intrahepatic Cholangiocarcinoma
por: Mao, Jinzhu, et al.
Publicado: (2021) -
MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma
por: Ma, Xijuan, et al.
Publicado: (2020)